Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
Eli Lilly has signed a new research deal with BigHat Biosciences to co-develop next-generation antibody therapeutics, as the pharma company continues to expand its capabilities in artificial intelligence (AI)-driven drug development.
The agreement covers up to two antibody programmes, with BigHat responsible for the design and engineering of therapeutic antibodies using its proprietary Milliner platform. Financial terms of the deal have not been disclosed.
The Milliner platform combines machine learning (ML) with a synthetic biology-based high-speed wet lab to address key challenges in antibody development. The technology is designed to optimise multiple antibody attributes simultaneously – including affinity, specificity, immunogenicity, and manufacturability – with the goal of accelerating the development of biologics with improved therapeutic profiles.
As part of the agreement, Lilly is making an equity investment in BigHat and providing additional support through its Catalyze360 initiative. This includes backing BigHat's internal gastrointestinal (GI) cancer antibody-drug conjugate (ADC) programme, which is expected to enter clinical trials in 2026. BigHat will retain full global rights and development control over the ADC.
The deal represents a continued push by Lilly to expand its use of AI in drug discovery and development. In 2023, the company partnered with OpenAI to identify new antimicrobials targeting drug-resistant bacteria and announced a $409m deal in 2024 with Genetic Leap, focused on RNA-targeted therapies.
This news was announced the same day (17 April) as high-profile results from Eli Lilly's oral glucagon-like peptide-1 receptor agonist (GLP-1RA) drug orforglipron, which sent the multibillion-dollar pharma company's shares to increase significantly.
For BigHat, the collaboration with Lilly adds to a growing portfolio of strategic partnerships. The company has previously announced research collaborations with Johnson & Johnson (J&J) focused on neuroscience applications and with AbbVie in a deal that included a $30m upfront payment and up to $325m in milestones. The AI-driven company has also struck deals with MSD and Amgen.
Founded in 2019, BigHat is advancing a pipeline of preclinical programmes across oncology and immunology. These include next-generation ADCs and functionally differentiated T-cell engagers (TCEs). In November 2024, BigHat acquired commercial licensing rights to Synaffix's site-specific ADC technology platform, which it is using in its lead GI cancer ADC programme. The programme is currently in the investigational new drug (IND)-enabling stage and is expected to become BigHat's first clinical candidate.
'Partnering with Lilly represents an exciting opportunity to harness the full potential of AI-driven biologic design,' said Peyton Greenside, CEO of BigHat, in the 17 April announcement.
Many drug companies have begun using AI to streamline the drug development process. Speaking on a panel at the 2024 BIO CEO & Investor Conference in New York on 27 February 2024, BigHat's chief business officer Liz Schwarzbach said that AI can act as a 'toolkit' to expand what the industry can already do.
According to a survey by GlobalData, the parent company of Pharmaceutical Technology, AI is considered the most disruptive technology among businesses, including in the healthcare industry.
"Eli Lilly and BigHat Biosciences ink AI antibody discovery deal" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
16 hours ago
- New York Post
Hairstylists, medical expert confirms this side effect for Ozempic users
Side effects from GLP-1s can vary, but one lesser-known reported outcome of the popular weight-loss medications is hair loss or thinning. Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys. Advertisement This includes Ashley DiMatteo, owner of Ashley Lauren Beauty Lounge in Westchester, New York, and Briana Delvecchio, a color specialist and hairdresser at DiMatteo's salon. The two spoke with Fox News Digital in an on-camera interview. 'There has definitely been an increase in clients coming in with hair loss,' DiMatteo said, noting that it ranges from gradual to fast, and from thinning out to completely losing hair. Delvecchio agreed that she's had 'a few' clients come in reporting thinner and drier hair, which she suspects could be due to weight-loss drugs. The hairstylist, who herself takes a GLP-1 drug, said there may be a few reasons for hair changes, including new medications, vitamin deficiencies, and weight loss, which can put stress on the body. Advertisement Becky Watt, an Ohio hairstylist with more than 20 years of experience, said she's also noticed clients losing hair while taking weight-loss drugs. 'I've seen thinning and shedding, and a lot of hair coming out very easily when being washed,' she told Fox News Digital. 'I have not noticed any bald spots.' 6 Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys. blackday – She's had some clients, however, who are taking the medications without any hair loss, Watt added. Medical factors Advertisement In a separate interview, Dr. Philip Rabito, an endocrinologist in New York City, said this reaction, called telogen effluvium, is a stress response to weight loss that affects the hair follicle. The response is only temporary, he noted. The hair will fall out, then grow back once the weight loss stabilizes after a few months. 'It's a response to severe physical stress, and weight loss is considered starvation,' Rabito said. 'It is the rapidity of the weight loss that correlates with the amount of hair loss.' 6 Ashley DiMatteo, owner of Ashley Lauren Beauty Lounge in Westchester, New York, and Briana Delvecchio, a color specialist and hairdresser at DiMatteo's salon, have noticed that some of their clients' hair has been thinning due to their weight loss journey. FOX News Digital Advertisement Before weight-loss drugs, traditional bariatric surgery would lead to the loss of 70% of excess body weight in about six months, Rabito said, which was often followed by hair loss within six to nine months. 'Your body doesn't understand that this is healthy weight loss — your body thinks it's starving,' he reiterated. 'It happens to almost everyone, to some people more than others.' Those who lose weight more repetitively are at higher risk of hair loss, Rabito said, as well as those who have an underlying thyroid issue or micronutrient deficiency, typically in iron, B12, or vitamin D. These vitamin deficiencies can worsen as weight loss occurs, so it's important to work with a medical professional to balance these levels, according to the doctor. 6 Delvecchio said that she's had 'a few' clients come in reporting thinner and drier hair, which she suspects could be due to weight-loss drugs. FOX News Digital 'From what I have learned from talking to these specific clients, it seems that the clients that are still eating don't have the hair loss,' Watt observed. 'It seems that my clients who say they don't have any appetite whatsoever are the ones losing the most hair,' she continued. 'I believe that's possibly due to lack of nutrients and protein, although I'm no doctor.' Tips for managing hair loss Advertisement DiMatteo and Delvecchio agreed they 'always' advise their clients to see their doctor for a vitamin level check. 'And we will also then taper their hair routine,' DiMatteo said. 'Basically, less is more during hair loss.' The salon owner suggested keeping up with scalp treatment, reducing the use of heat, brushing from the bottom up, and avoiding going to bed with wet hair. 'Check in with your weight-loss doctor or your endocrinologist prior to coming to us to rule out iron, vitamin D, or anything that you're lacking — we need to rule that out before we can help you,' Delvecchio said. Advertisement 'Then we'll tell you we need to work on your scalp health; we'll give you shampoo and conditioner that may be a little gentler for your hair.' 'Scalp stimulation is huge,' DiMatteo added. 'Rinsing with cool water helps as well. Try not to do harsher treatments in the sense of lightening or coloring — spread it out as much as possible.' Rabito noted that losing hair is 'part of the game.' He said he always warns his patients before starting their weight-loss journey that this will most likely occur and is a 'mark of success.' Advertisement 6 Dr. Philip Rabito (not pictured), an endocrinologist in New York City, said this reaction, called telogen effluvium, is a stress response to weight loss that affects the hair follicle. Wild Awake – 'They're going to lose hair,' he said. 'It's going to get worse before it gets better.' 'But as long as you get the vitamins controlled, get them adequately repleted — when the patient plateaus and the weight is stable for a month or two, the body doesn't sense starvation anymore, and the body is less stressed, then the hair grows back better than ever.' Watt said she often recommends a hair vitamin to her clients struggling with weight loss. 'Diet also has a lot to do with it,' she noted. Advertisement 6 When previously contacted, Novo Nordisk — the maker of Ozempic and Wegovy — confirmed that hair loss is an identified risk for semaglutide, and is listed as a side effect in the product information. mbruxelle – She also recommended using a shampoo and conditioner that are formulated to resist thinning and hair loss, along with a bond-building hair product. DiMatteo and Delvecchio assured those who are experiencing hair loss that regrowth does take time, and that there's no need for excessive hair growth treatments. Delvecchio added, 'The hair loss is temporary. It's a positive stress, and it's worth it.' When previously contacted by Fox News Digital, Novo Nordisk — the maker of Ozempic and Wegovy — confirmed that hair loss is an identified risk for semaglutide, and is listed as a side effect in the product information. 6 DiMatteo and Delvecchio assured those who are experiencing hair loss that regrowth does take time, and that there's no need for excessive hair growth treatments. doucefleur – 'In clinical trials of Wegovy, hair loss was reported in 2.5% of Wegovy-treated adult patients versus 1.0% of placebo-treated adult patients,' the company spokesperson said at the time. 'Hair loss was reported more frequently in patients with greater weight loss (≥20%), suggesting that the events of hair loss were potentially related to the magnitude of weight loss.' 'Patient safety is of utmost importance to Novo Nordisk,' the statement continued. 'We are continuously monitoring the safety profile of our products and collaborate closely with authorities to ensure patient safety, including adequate information on hair loss.'
Yahoo
21 hours ago
- Yahoo
Weight-Loss Medications Less Effective for People in the 'Real World,' New Study Finds
A new study analyzed patients who used GLP-1 medications in a real-world setting Researchers found that participants lost less weight compared to use in clinical trials They believe discontinuation rates are due to high out-of-pocket costs, issues with insurance coverage, side effects and supply shortagesWeight-loss medications like Ozempic and Mounjaro are not as effective in a 'real-world' setting, according to a new study. The study — published June 10 in the Obesity Journal — analyzed nearly 8,000 patients who were classified as having severe obesity. Between 2021 and 2023, they were treated with semaglutide or tirzepatide, injectable GLP-1 medications, in a real-world setting. GLP-1 is short for glucagon-like peptide-1 receptor agonists, which work in the brain to impact satiety. Semaglutide is sold under brand names Ozempic and Wegovy, and tirzepatide is sold under brand names Mounjaro and Zepbound. In a follow-up study, which ended in December 2024, researchers grouped patients who discontinued their obesity medications into those who discontinued early (within 3 months) and late (within 3-12 months). Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! They found that more than 20% of patients discontinued their medications early and 32% discontinued their medications late. Additionally, more than 80% of patients were on lower maintenance dosages of their medications. After a year of treatment, the average weight loss was 3.6% for those who discontinued their treatment early, compared to 6.8% for those who discontinued their treatment late. Those who continued treatment lost about 12% of their body weight. During clinical trials for the GLP-1s, patients lost about 15% to 20% of their body weight. 'Our findings about the real-world use patterns of these medications and associated clinical outcomes could inform the decisions of healthcare providers and their patients on the role of treatment discontinuation and maintenance dosage in achieving clinically meaningful weight reductions,' Dr. Hamlet Gasoyan, Cleveland Clinic researcher and lead author of the study, said in a statement. The study notes that discontinuation rates during real-world use were higher than those in a clinical trial setting due to high out-of-pocket costs, issues with insurance coverage, side effects and supply shortages. Read the original article on People
Yahoo
21 hours ago
- Yahoo
Hairstylists and medical expert confirm temporary hair loss affecting Ozempic users
Side effects from GLP-1s can vary — but one lesser-known reported outcome of the popular weight-loss medications is hair loss or thinning. Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys. This includes Ashley DiMatteo, owner of Ashley Lauren Beauty Lounge in Westchester, New York, and Briana Delvecchio, a color specialist and hairdresser at DiMatteo's salon. The two spoke with Fox News Digital in an on-camera interview (see the video at the top of the article). Is Ozempic Ruining Your Teeth? What To Know About Impact On Dental Health "There has definitely been an increase in clients coming in with hair loss," DiMatteo said, noting that it ranges from gradual to fast, and from thinning out to completely losing hair. Delvecchio agreed that she's had "a few" clients come in reporting thinner and drier hair, which she suspects could be due to weight-loss drugs. Read On The Fox News App The hairstylist, who herself takes a GLP-1 drug, said there may be a few reasons for hair changes — including new medications, vitamin deficiencies and weight loss, which can put stress on the body. Becky Watt, an Ohio hairstylist with more than 20 years of experience, said she has also noticed clients losing hair while taking weight-loss drugs. "I've seen thinning and shedding, and a lot of hair coming out very easily when being washed," she told Fox News Digital. "I have not noticed any bald spots." However, she has had some clients who are taking the medications without any hair loss, Watt added. In a separate interview, Dr. Philip Rabito, an endocrinologist in New York City, explained that this reaction, called telogen effluvium, is a stress response to weight loss that affects the hair follicle. Ozempic, Other Semaglutides Linked To Hair Loss: Here's What To Know The response is only temporary, he noted — the hair will fall out and then grow back once the weight loss stabilizes after a few months. "It's a response to severe physical stress — and weight loss is considered starvation," Rabito said. "It is the rapidity of the weight loss that correlates with the amount of hair loss." Before weight-loss drugs, traditional bariatric surgery would lead to the loss of 70% of excess body weight in about six months, Rabito shared — which was often followed by hair loss within six to nine months. "Your body doesn't understand that this is healthy weight loss — your body thinks it's starving," he reiterated. "It happens to almost everyone, to some people more than others." This Daily Beauty Routine Could Be Ruining Your Hair, Experts Warn Those who lose weight more repetitively are at higher risk of hair loss, Rabito said, as well as those who have an underlying thyroid issue or micronutrient deficiency — typically in iron, B12 or vitamin D. These vitamin deficiencies can worsen as weight loss occurs, so it's important to work with a medical professional to balance these levels, according to the doctor. "From what I have learned from talking to these specific clients, it seems that the clients that are still eating don't have the hair loss," Watt observed. "It seems that my clients who say they don't have any appetite whatsoever are the ones losing the most hair," she went on. "I believe that's possibly due to lack of nutrients and protein, although I'm no doctor." DiMatteo and Delvecchio agreed that they "always" advise their clients to see their doctor for a vitamin level check. "And we will also then taper their hair routine," DiMatteo said. "Basically, less is more during hair loss." The salon owner suggests keeping up with scalp treatment, reducing the use of heat, brushing from the bottom up and avoiding going to bed with wet hair. "Check in with your weight-loss doctor or your endocrinologist prior to coming to us to rule out iron, vitamin D or anything that you're lacking — we need to rule that out before we can help you," Delvecchio said. "Then we'll tell you we need to work on your scalp health; we'll give you shampoo and conditioner that may be a little gentler for your hair." "Scalp stimulation is huge," DiMatteo added. "Rinsing with cool water helps as well. Try not to do harsher treatments in the sense of lightening or coloring — spread it out as much as possible." Rabito noted that losing hair is "part of the game" — he said he always warns his patients before starting their weight-loss journey that this will most likely occur and is a "mark of success." "They're going to lose hair," he said. "It's going to get worse before it gets better." "But as long as you get the vitamins controlled, get them adequately repleted — when the patient plateaus and the weight is stable for a month or two, the body doesn't sense starvation anymore, and the body is less stressed, then the hair grows back better than ever." Watt said she often recommends a hair vitamin to her clients struggling with weight loss. "Diet also has a lot to do with it," she noted. She also recommends using a shampoo and conditioner that are formulated to resist thinning and hair loss, along with a bond-building hair product. Click Here To Sign Up For Our Health Newsletter DiMatteo and Delvecchio assured those who are experiencing hair loss that regrowth does take time, and that there's no need for excessive hair growth treatments. Delvecchio added, "The hair loss is temporary. It's a positive stress, and it's worth it." When previously contacted by Fox News Digital, Novo Nordisk — maker of Ozempic and Wegovy — confirmed that hair loss is an identified risk for semaglutide, and is listed as a side effect in the product information. "In clinical trials of Wegovy, hair loss was reported in 2.5% of Wegovy-treated adult patients versus 1.0% of placebo-treated adult patients," the company spokesperson said at the time. For more Health articles, visit "Hair loss was reported more frequently in patients with greater weight loss (≥20%), suggesting that the events of hair loss were potentially related to the magnitude of weight loss." "Patient safety is of utmost importance to Novo Nordisk," the statement continued. "We are continuously monitoring the safety profile of our products and collaborate closely with authorities to ensure patient safety, including adequate information on hair loss." Melissa Rudy contributed article source: Hairstylists and medical expert confirm temporary hair loss affecting Ozempic users
